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Abstract 208 words 
Inflammatory neovascularization, such as choroidal neovascularization (CNV), occur in the presence 
of Notch expressing macrophages and endothelial cells (EC). The influence of DLL4 induced Notch 
signaling on macrophages and its overall effect in inflammatory neovascularization is not well 
understood. We identified macrophages and ECs as the main Notch1 and Notch 4 expressing cells in 
CNV. A soluble fraction spanning Ser28-Pro525 of the murine extracellular DLL4 domain 
(sDLL4/28-525) activated the Notch pathway, as it induces Notch target genes in macrophages and 
ECs and inhibited EC proliferation and vascular sprouting in aortic rings. In contrast, sDLL4/28-525 
increased pro-angiogenic VEGF, IL1- expression in macrophages  responsible for increased 
vascular sprouting observed in aortic rings incubated in supernatants from sDLL4/28-525 stimulated 
macrophages. In vivo, Dll4
+/-
 mice developed significantly more CNV and sDLL4/28-525 injections 
inhibited CNV in Dll4
+/-
 CD1. Conversly, sDLL4/28-525 inhibited CNV in C57Bl6 and its effect 
was reversed by a -secretase inhibitor that blocks Notch signalling. The inhibition occurred despite 
increased VEGF, IL1- expression in infiltrating inflammatory macrophages in sDLL4/28-525 
treated mice and might be due to direct inhibition of EC proliferation in laser-induced CNV as 
demonstrated by EdU labelling in vivo. In conclusion, Notch activation on macrophages and ECs 
leads to opposing effects in inflammatory neovascularization in situations such as CNV.  
Key words: Angiogenesis, Notch, DLL4, eye, age related macular degeneration, macrophages 
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Introduction 
Angiogenesis is a hallmark in development, tissue repair and in pathological conditions such as 
cancer and age related macular degeneration (AMD) [1]. In angiogenesis, specialized endothelial 
cells at the tip of the forming vascular sprout (“tip cells”) guide the proliferating, lumen forming, 
“stalk cells” [2] to form new blood vessels. Delta-like 4 (DLL4) has been shown to play an 
important role in this process. 
DLL4 is a member of membrane-bound proteins (Delta-like 1, 3, and 4 and Jagged1 and 2) that 
activate the four Notch receptors (Notch1–4) [3]. Ligand binding to Notch induces the proteolytic 
release by the -secretase of the Notch intracellular domain (NICD) that translocates to the nucleus 
where it regulates gene expression of specific target genes such as HES1 and HEY1 [4]. Soluble 
Notch ligands can act as agonists [5-7] or antagonists [8] [9]. To activate Notch, it has been 
proposed that the Notch ligand has to be fixed to a support to enable it to tether the Notch 
extracellular domain away from the NICD (for review see D’Souza [4]). The report of soluble 
peptide agonists questions this hypothesis [6]. 
Notch-signaling pathways are involved in lateral inhibition in the differentiation of a variety of 
tissues [3]. Tip cells and arterial endothelial cells specifically express DLL4 [10][10, 11]. DLL4 
down regulates VEGF receptor (VEGFR) expression on neighboring stalk cells and inhibits their 
differentiation into tip cells and their proliferation [12-14]. It is regulated by VEGF and has been 
proposed to act as a negative feedback to prevent over exuberant angiogenic sprouting and to allow 
the formation of an orderly vascular network [14, 15]. DLL4 exerts this effect via Notch 1 and Notch 
4 activation [10, 16], the two DLL4 receptors expressed on endothelial cells [11], but does not bind 
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to Notch 3 [17]. DLL4-mediated Notch signaling is essential for embryonic vascular development 
[15, 18, 19]. Pharmacological DLL4 inhibition leads to exuberant but malfunctioning vessel 
formation in tumors and consequently tumor growth inhibition [20] and has been proposed as a 
possible therapy of tumors [21] [20]. Recent evidence that chronic DLL4 inhibition induces vascular 
neoplasms [22] casts doubt on the safety of this approach.  
In neovascularization, observed in ischemia, tumor growth and inflammatory conditions, infiltrating 
cells from the myeloid lineage, such as macrophages, are key players [23-25] as an abundant source 
of angiogenic factors [1, 23, 26], notably vascular endothelial growth factor (VEGF), Interleukin 1, 
TNF-, and interleukin 6 [26]. Notch signaling plays an important role in myeloid cell 
differentiation [27] and in the regulation of cytokine expression in mature macrophages [28] [29] 
[30]. Resting macrophages express all four Notch receptors [28, 29] and activated macrophages 
selectively further increase Notch1 expression [29]. Notch pathway inhibition in bone marrow 
derived macrophages leads to an M2 (angiogenic) polarization of macrophages [30, 31]. Myeloid 
specific Notch-1 deletion decreased monocytic VEGFR 1 expression and monocyte recruitment to 
the injury site [30]. Furthermore, systemic soluble DLL4 over-expression enhances leukocyte 
recruitment and leads to chaotic neovascularization in ischemia [9]. The influence of DLL4 and 
Notch signaling on macrophage angiogenic factor release is unknown. Taken together Notch 
signaling in monocyte recruitment and macrophage activation in pathological neovascularization is 
still ill defined. 
Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the world 
[32]. The fast progressive “wet” form is characterized by leaky subretinal choroidal 
neovascularisation (CNV) that leads to extravasations and hemorrhage into the photoreceptor cell 
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layer and photoreceptor cell loss [32]. CNV are dependent on vascular endothelial growth factor 
release [33] from the retinal pigment epithelium and macrophages [34, 35] that accumulate in the 
subretinal space in AMD [36]. The recruitment of monocytes to the subretinal space and the release 
of VEGF have been shown to be crucial in the development of “wet” AMD [37, 38]. 
We here investigated the role of DLL4 signaling in macrophages and endothelial cells and its overall 
effect on choroidal neovascularization.  
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Material and methods 
Animals 
Twelve-week old C57Bl/6J mice (Janvier, France) and six month old Dll4
+/-
 mice bred on a CD1 
background [19] [39] and CD1 (Dll4
+/+
) control mice (Janvier, France) were used. Mice were 
kept in specific pathogen-free conditions with food and water available ad libitum and housed in 
a 12/12hr light/dark cycle. The care and use of the animals was in compliance with the Centre de 
Recherche Committee for animal experimentation. 
CNV induction 
Mice were anesthetized by intramuscular injection of ketamine (50 mg/kg) and xylazine (10 
mg/kg). In pigmented animals (C57BL6) the pupils were fully dilated with 1% tropicamide. 
Cover slips positioned on the mouse cornea were used as a contact glass. Laser-coagulations were 
performed 4 to 5 disc diameters away from the papillae with an Argon laser (532 nm, 400 mW, 
50 ms and 50 μm). Treatment consisted either of 4 µg of recombinant soluble DLL4 (R&D 
systems Europe, France) diluted in 2 µl or vehicle, injected in the vitreous 0d and 4d of laser 
injury.  
In albino CD1 (Dll4
+/+
) and Dll4
+/-
 mice we induced CNV by “cryogenic lesion”, as laser-induced 
RPE lesions cannot be induced with a 532nm laser in albino animals. Briefly, a RPE/Bruchs 
membrane lesion was produced by inserting a liquid nitrogen cooled 30 gauge syringe through 
the sclera. The syringe was left in place for 5 seconds inducing the death of RPE cells. This 
injury results in CNV similar to the laser-induced model in pigmented animals.  
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After sacrifice the eyes were fixed in PBS/PAF 4%. The eyes were either cryo-sectioned for 
immunohistochemistry of Notch receptors at 3d or the choroids were dissected and CNV was 
quantified on CD102 stained flat mounts at 14d using Image J Software (NIH, USA).  
For determination of ECs proliferation in the laser impact in vivo, mice were injected i.p. daily 
with EdU (5-ethynyl-2´-deoxyuridine ; 50mg/kg body weight). Choroid whole mounts collected 
at day 4 following CNV induction were stained with collagen IV and the Click-iT® EdU A-594 
Imaging Kit following manufacturer’s instructions (Invitrogen France). 
Immunohistochemistry 
Retinal and choroidal human whole mounts were post-fixed with cold acetone for 15 minutes. 
After washing with PBS, whole mounts were incubated overnight with primary antibodies diluted 
in PBS Triton 0.1%. Mouse eye sections were incubated in PBS diluted antibodies. The 
following primary antibodies were used: human/mouse Notch1 (AF3647, R&D systems, France), 
rabbit polyclonal anti human/mouse Notch4 (ab23427, Abcam, Cambridge, UK), rabbit anti 
human/mouse HES1 (ab71-559, Abcam, Cambridge, UK), rabbit anti human DLL4 (ab7280, 
Abcam, Cambridge, UK), rat anti-mouse CD102 (clone 3C4, BD Biosciences Pharmingen), rat 
anti-CD31 (Clone MEC 13.3, BD Biosciences Pharmingen), rabbit polyclonal antibody anti 
IBA1 (Wako pure chemical industries; Osaka, Japan), rabbit anti VEGF (sc-507, Santa Cruz), rat 
anti-human CD18 (MCA503; Abd Serotec, UK), rat anti mouse CD68 (MCA1957S, Abd 
Serotec, UK), rat anti-F4/80 (MCA497G, Abd Serotec, UK) and goat anti human collagen IV 
(Abd Serotec, UK). 1:400 PBS diluted corresponding Alexa-fluorescent-conjugated secondary 
antibodies (Invitrogen, OR, USA) were used to reveal the primary antibodies. Sections and whole 
mounts were viewed with a fluorescence microscope (DM5500 B Leica, France) or a confocal 
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microscope (Zeiss LSM 510 or LSM 710). All immuno-staining were repeated at least 3 times. 
Staining that omitted the primary antibody served as negative controls. 
RNA Isolation and quantitative reverse transcription PCR 
Total RNA were extracted with NucleoSpin RNAII kit (Macherey-Nagel EURL, France) and 
transcribed into cDNA. The cDNA product was amplified using the LightCycler FastStart DNA 
master SYBR green I mix and a Light Cycler 1.5 apparatus. The primers used for PCR are 
presented in Table 1. The mRNA levels were normalized to beta actin mRNA. 
Enzyme-linked immune-adsorbent assay (ELISA) 
Mouse VEGF concentrations were measured in lysates of retina and choroid, and in macrophage 
supernatants using ELISA assay following manufacturer’s protocol (R&D System, France).  
Peritoneal macrophages preparation and stimulation 
Mouse peritoneal exudate cells (PECs) were elicited by i.p. injection of 2 ml 3% thioglycollate 
(T9032, Sigma) into 8–10-week-old C57BL/6j mice. After 4 days, PECs were isolated by 
flushing of the peritoneum with 4 ml ice-cold PBS containing 5 mM EDTA (Sigma). PECs were 
incubated 6h at 37°C in a 5% CO2 atmosphere in RPMI 1640 medium containing 10% FCS in 
order to let macrophages adhere to the wells. The medium and floating cells were removed and 
replaced by RPMI 1640 without serum with or without 1g/ml of recombinant sDLL4/28-525. 
Supernatants were collected at indicated times for ELISA and macrophages were lysed in 300l 
RA1 buffer (Macherey-Nagel EURL, France) for mRNA extraction. 
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Flow cytometry 
One million mouse PECs were incubated in ice-cold PBS medium (Blocking buffer) containing 5 
mM EDTA (Sigma Aldrich, France), 1% FCS, 3% normal rat and mouse serum, and 10% mouse 
Seroblock FCR (Abd Serotec, UK). Macrophages were stained 25 minutes on ice with APC-
conjugated rat anti-mouse F4/80 (MCA497APC) and PE-coupled rat anti-mouse CD11b 
(MCA711PE, Serotec). Cells were washed and incubated in permeabilization buffer (eBiosciences) 
before staining with the Notch1 (AF3647, R&D systems, France) and Notch4 (ab23427, Abcam, 
Cambridge, UK) intracellular domain antibodies. After a second wash cells were incubated with 
Fitc-labeled anti-sheep and rabbit antibodies respectively. After a final wash acquisitions were 
performed on a LSRII cytometer (BD Bioscience). Expression of Notch1 and 4 by macrophages 
gated for CD11b-PE and F4/80-APC expression was analyzed and illustrated using the Flow Jo V7.9 
software. 
CNV-recruited macrophages sorted by flow cytometry 
Neovascularization was induced by ten laser impacts per eye in 11 weeks old males C57Bl/6J mice. 
Three days later, a single injection was done in vitreous with 2ul PBS or DLL4 (1ug/µl). The next 
day, eight control and eight DLL4-treated eyes were dissected to isolate the choroides. Tissues were 
dissociated in HBBS buffer containing Liberase LT (1,7 Wünsch unit/ml) and DNaseI 
(100ug/ml)(Roche Diagnostics) 30 minutes at 37°C. Cells were washed with ice-old HBBS then 
with PBS. Whole cells were resuspended in Blocking Buffer 15 minutes at 4°C. Then they were 
stained with APC-conjugated rat anti-mouse F4/80, PE-coupled rat anti-mouse CD11b and FITC-
coupled rat anti-mouse LY6B.2 alloantigen (Clone 7/4, Abd Serotec). Recruited inflammatory 
macrophages were sorted directly in Lysis Buffer as CD11b
high
 F4/80
+
 LY6B.2
+
. mRNAs were 
extracted using the Kit Nucleospin RNA XS (Macherey Nagel). 
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Western blot 
PECs incubated with PBS or sDLL4/28-525 were lysed in ice-cold Tris-HCl 50mM pH 6,8 and SDS 
2% and PMSF 2mM and anti-protease cocktail (Sigma). Protein preparation, electrophoresis and 
transfer on nitrocellulose membrane were performed following supplier’s instructions (Invitrogen, 
France). The Notch4 intracellular domain (N4-ICD, 52Kda) was detected with the rabbit polyclonal 
anti human/mouse Notch4 (1:500, ab23427, Abcam, UK). Anti-O-actin (1:5000, Santa Cruz, US) 
was used to control for protein loading. Proteins were revealed by corresponding secondary 
horseradish peroxydase-conjugated antibodies (Vector, US). 
Aortic ring assay 
Aortae from adult C57BL6 were cut into 1-mm-thick rings and covered with 30 μL of Matrigel 
(BD Biosciences, France). Aortic rings were cultured for 3 days in Dulbecco’s Modified Eagle’s 
Medium (DMEM, Invitrogen, France) containing 10% FCS, 1% penicillin/streptomycin, and 
0.2% fungizone. Explants were exposed to sDLL4/28-525 (2g/mL; R&D system, France), or 
supernatants harvested from LPS (0.1g/ml) activated macrophages under different conditions: 1. 
control; 2. sDLL4/28-525 (1g/mL) stimulated; 3. sDLL4/28-525 (1g/mL) DAPT stimulated 
macrophages 0.1g/ml of LPS in presence or not of sDLL4/28-525 (1g/ml), from day 3 to day 5 
of culture. VEGF The surface covered by the aortic ring and the vascular sprouts was measured 
daily. Vascular sprouting was calculated for each day and aortic ring as the percentage of the area 
covered at day 3. 
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Endothelial cell culture and proliferation assays in vitro 
Human umbilical vein endothelial cells (HUVEC) were isolated by collagenase dissociation (Roche 
Diagnostic, France). HUVECs from 5 different donors were used between passage 4 and 6. Cells 
were cultured in EBM (Clonetics, France) supplemented with 10% FCS and 2 ng/ml of VEGF every 
other day. The medium was changed every 4 days. Hes-1 and Hey-1 expression were analysed in 
control and sDLL4/28-525 (1g/ml) incubated ECs by rt-PCR. For 3H-thymidine incorporation 
proliferation assay, two thousand cells per well were plated on a 96 well plate for 24h in EBM 
medium containing 10% FCS at 37°C in a 5% CO2 atmosphere. The cells were “starved” for 48h in 
EBM medium containing 1% albumax. HUVEC were stimulated 96h with 20 ng/ml of VEGF and 
with 1 g/ml of sDLL4/28-525. Radioactive 3H-thymidine (1Ci/well) was added to each well 
during the last 16 hours. Cells were washed before reading of their radioactivity; a direct measure of 
proliferation was performed in a beta counter (TopCount NXT, Perkin Elmer, USA). 
Endothelial cells apoptosis analysis by TUNEL and AnnexinV detection kit 
Sixteen thousand HUVEC, per well were plated on a 12 wells plate. HUVEC were cultivated in 
EBM 1% albumax (Gibco
TM
 AlbuMAX, Invitrogen) alone or with VEGF 50ng/ml or VEGF and 
1g/ml of DLL4 for another 24h. Terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) assay was performed to determine the number of apoptotic cells as described by 
manufacturer’s protocol (In Situ Cell Death Detection Kit, Roche Diagnostics). For flow cytometrie, 
cells were stained with AnexinV-FITC apoptosis detection kit and Propidium iodide staining 
solution (eBiosciences, Clinisciences France) to detect apoptotic- (AnexinV-positive, Pi-negative) 
and necrotic- (AnexinV-negative, Pi-positive) cells using a FACScan cytofluorimeter using PC lysis 
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II software (Beckton Dickinson CO, Mountain view, CA, USA). The total percentage of dying cells 
was considered as the sum of percentage of apoptotic and necrotic cells. 
Statistical Analysis 
Graph Pad Prism 5 (GraphPad Software) was used for data analysis and graphic representation. Data 
are presented as mean ± standard deviation (SD). Statistical comparisons used unpaired two-sample 
t-tests for RT-PCR results, Mann Whitney t-tests for CNV areas comparison, one way ANOVA 
followed by the Bonferoni multiple comparison test for HUVEC proliferation assay and two way 
ANOVA followed by the Bonferoni multiple comparison test for growth of aortic ring kinetics.  P-
values less than 0.05 were considered statistically significant. 
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Results 
Notch1 and 4 are expressed in endothelial cells and cells macrophages in choroidal 
neovascularization 
DLL4 binds and activates Notch 1 and Notch 4 [10, 16] but does not bind to Notch 3 [17]. Notch1 
and 4 are expressed on retinal endothelial cells [11] during angiogenesis, but also on macrophages 
[28, 29] that participate in choroidal neovascularization (CNV) [37, 38]. To identify DLL4 sensitive 
cells in CNV we performed Notch 1 and Notch 4 immunohistochemistry on mice 3days after CNV 
inducing laser-injury. Notch 1 staining (Fig. 1A) was detected in the CD31 positive (Fig. 1B, merge 
C) choroidal endothelial cells in CNV. Similarly, Notch 4 staining (Fig. 1D) was detected in the 
CD31 positive (Fig. 1E, merge F) choroidal endothelial cells in CNV. Choroidal vasculature in 
uninjured mice or distant from the laser-injury showed no staining (data not shown). Furthermore, 
3d after laser injury, Notch 1 staining (Fig. 1 G) was detected in CD68 positive macrophages (Fig 
1H, merge I) adjacent to the laser-impact. To a lesser extent, Notch 4 (Fig. 1J) was detected in some, 
but not all, CD68 positive (Fig. 1 K, merge L) cells.  
sDLL4 activates Notch signaling and induces proangiogenic mediators in macrophages. 
Resting macrophages express all 4 Notch receptors [28, 29] and LPS stimulation selectively further 
increase Notch1 and DLL4 expression [29]. To analyze Notch 1 and Notch 4 expression on mouse 
peritoneal exudate cells (PECs), we gated on F4/80 and CD11b (Fig. 2A) and analyzed Notch1 (Fig. 
2B), Notch4 (Fig. 2C) and DLL4 (Fig. 2D) expression. Anti-Notch1 and anti-Notch4 revealed with 
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secondary FITC coupled antibodies both significantly increased cell fluorescence of PECs prepared 
4 days after thioglycollate injection.  
Ligand binding to Notch induces the proteolytic release of the Notch intracellular domain (NICD) 
that translocates to the nucleus where it regulates gene expression of specific target genes such as 
HES1 and HEY1 [4]. To activate Notch, it has been proposed that the Notch ligand has to be fixed to 
a support to enable it to tether the Notch extracellular domain away from the NICD (for review see 
D’Souza [4]). However, recent evidence suggests that soluble Notch ligands can also act as agonists 
[5-7]. To test if the commercially available DLL4 (DLL4/28-525), composed of Ser28 - Pro525 with 
a C-terminal 10-His tag, in its soluble or anchored form affects the Notch pathway in macrophages 
we incubated PECs from C57Bl6 mice with anchored DLL4/28-525 (Fig. 2E) or soluble 
DLL4/28-525 (Fig. 2F) and analyzed HES-1 induction (HEY-1 expression was undetectable in 
PECs, data not shown). Our results show that both, anchored and soluble DLL4/28-525 induced 
Notch downstream gene HES-1 similarly and significantly in macrophages. Furthermore, soluble 
DLL4/28-525 (sDLL4/28-525) increased Notch4 cleavage of the intra cellular domain (N4-ICD) 
(Fig. 2G) and inhibition of the -secretase by DAPT prevented the significant HES-1 mRNA 
induction of sDLL4/28-525 in activated macrophages in which an angiogenic state was induced by 
LPS incubation [40] (Fig. 2H). To evaluate if DLL4 induced Notch signalling influenced the 
expression of pro-angiogenic mediators, we incubated activated macrophages with sDLL4/28-525 
and analyzed VEGF (Fig. 2I), IL1- (Fig. 2J), IL-6 (Fig. 2K), and TNF- (Fig. 2L) expression. 
sDLL4/28-525 significantly induced mRNA of all four genes and co-incubation with -secretase 
inhibitor DAPT prevented this effect. 
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sDLL4 activates Notch signaling in HUVEC and inhibits their proliferation. 
To analyze if sDLL4/28-525 activates the Notch pathway in endothelial cells (EC), we incubated 
HUVEC with un-bound sDLL4/28-525 and analyzed HES-1 and HEY-1 expression. sDLL4/28-525 
induced the Notch target genes HES1 and HEY1 significantly, although less strongly than in 
macrophages -secretase inhibitor DAPT prevented the mRNAs induction (Fig. 3A and B). DLL4 
induced Notch activation has been shown to inhibit EC proliferation [20]. To test the effect of 
sDLL4/28-525 on EC we exposed VEGF stimulated HUVEC to sDLL4/28-525 for 16h and 
evaluated cell survival and proliferation by 
3
H-thymidine uptake. sDLL4/28-525 significantly 
reduced VEGF-induced HUVEC proliferation (Fig. 2C). No signs of sDLL4/28-525 induced cell 
death were detected by TUNEL assay (Fig. 3 D) and no significant differences were found for 
apoptotic Annexin V positive- Pi negative HUVECs or necrotic Annexin V negative- Pi positive 
HUVECs ((Fig. 3 E). 
sDLL4 directly inhibits vascular sprouting but accentuates the angiogenic phenotype of 
activated macrophages in vitro 
Activated macrophages are key players in pathological neovascularization [23-25] as an abundant 
source of angiogenic factors [1, 23, 26]. In neovascularization, therapeutically induced DLL4 
signaling will affect EC proliferation but also potentially growth factor release from activated 
macrophages. To study the differential effect on ECs and macrophages we used the aortic ring assay. 
Aortic rings were grown over a period of 5 days either in control conditions (Fig. 4A) or in the 
presence of sDLL4/28-525 from day 3 (Fig. 4B). Quantification of vascular growth, expressed as the 
surface covered by endothelial sprouts relative to the pre-exposure surface at day 3, shows a small 
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but significant inhibition of vascular sprouting by sDLL4/28-525 at day 5 (Fig. 4C). In a second set 
of experiments we exposed aortic rings from day 3 to day 5 to supernatants from control activated 
macrophages (Fig. 4D), sDLL4/28-525 incubated activated macrophages (Fig. 4E). Interestingly, 
aortic rings exposed to supernatants from sDLL4/28-525-stimulated macrophages showed a 
significant increase in vascular sprouting compared to control supernatants which was reversed 
when sDLL4 stimulated macrophageswere inhibited by -secretase DAPT (Fig. 4F). We have shown 
that sDLL4/28-525-stimulated macrophages produce a variety of potential proangiogenic factors, 
notably VEGF and IL1- (Fig. 2), two factors that have been shown to influence vascular outgrowth 
in aortic rings [41, 42]. To evaluate if the sDLL4-induced VEGF and IL1- were responsible for the 
increased aortic ring sprouting, IL-1 receptor antagonist (IL1Ra) and soluble VEGF receptor 1 
(sVEGFR1) were added to the supernatants when administered to the aortic ring assay. Interestingly, 
inhibition of VEGF and IL1- completely reversed the proangiogenic affect sDLL4/28-525-
stimulated macrophage supernatant (Fig. 4G). 
DLL4 mediated Notch activation inhibits choroidal neovascularization. 
Laser coagulation of the mouse choroid in pigmented C57Bl6 animals induces rupture of Bruchs 
membrane, a local inflammatory reaction and choroidal neovascularization (CNV) similar to “wet” 
AMD. Dll4
+/-
 C57BL6 mice are not viable [19] and to dispose of adult Dll4
+/-
 mice, we outbred the 
mice to a CD1 albino background. To induce CNV in albino mice we provoked a local injury using 
liquid nitrogen cooled needle that reproducibly induces CNV in pigmented as well as albino animals 
(complementary figure). CD102 stained choroidal flatmounts of cryo-injured Dll4
+/+ 
CD1 mice (Fig. 
5A) were significantly smaller than in Dll4
+/-
 CD1 mice (Fig. 5B). Furthermore, sDLL4/28-525 
injection in Dll4
+/-
 CD1 mice significantly reduced CNV development (Fig. 5C, CNV were 
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quantified as CD102 positive surface on flatmounts Fig. 5D). PBS control injections in Dll4
+/-
 CD1 
mice had no effect (Data not shown). Similarly, sDLL4/28-525 injections significantly inhibited 
laser-induced CNV (Fig. 5F) in wild type C56BL6 mice compared to PBS injections (Fig. 5E). 
Disruption of DLL4 signalling by -secretase inhibitor DAPT completely reversed the anti-
angiogenic effect of sDLL4/28-525 (Fig. 5G, CNV were quantified as collagen IV positive surface 
on flatmounts  Fig. 5H).  
Local sDLL4 administration does not alter macrophage recruitment but increases macrophage 
VEGF expression in vivo. 
Notch1 activation has been shown to regulate vascular endothelial growth factor receptor-1 in 
macrophages and myeloid specific Notch1 deletion decreases macrophage recruitment to skin 
lesions [30]. On the other hand systemic DLL4 inhibition has been suggested to increase leukocyte 
recruitment to the ischemic muscle [9]. To test whether local activation of notch signaling via 
intravitreal administration of sDLL4/28-525 altered the macrophage recruitment to the laser-injury 
site we stained choroidal flat mounts of PBS (Fig. 6A) or sDLL4/28-525 (Fig. 6B) injected eyes with 
the monocyte macrophage marker IBA-1. Quantification of IBA-1 positive cells at d4, when 
macrophage recruitment is maximal, revealed no difference in IBA-1 positive cells in the two groups 
(Fig. 6C). 
Notch signaling in macrophages has been shown to regulate cytokine expression [30, 31] and we 
observed a Notch dependent induction of VEGF, IL1- in sDLL4/28-525-incubated macrophages in 
vitro that induces increased vascular sprouting in aortic rings (Fig. 2 and 4). To evaluate if 
intravitreal sDLL4/28-525 altered the expression of these cytokines in vivo we analyzed IL1- and 
Serge Camelo, William Raoul, Sophie Lavalette et al. 
   19 
VEGF mRNA expression by rtPCR (Fig. 6 D and E) and VEGF protein expression by ELISA (Fig. 
6F) 24h after PBS or sDLL4/28-525 injection at 4d. Our results show that sDLL4/28-525 
significantly induces IL1- and VEGF in vivo. To more specifically analayze if sDLL4/28-525 
induces VEGF and IL1- in activated macrophages in the in vivo experiments, we performed rt-
PCRs on cells sorted by fluorescent activated cell sorted (FACS). Cell suspensions were prepared 
from choroids 4 days after laser-injury having received PBS or sDLL4 injections at d3. Experiments 
were performed on 8 pooled choroids per group. We gated CD11b
+
F4/80
+
 macrophages (Fig. 6G) 
and further differentiated into CD11b
+
LY6B.2
high
 inflammatory macrophages and 
CD11b
+
LY6B.2
low
 resident macrophages and dendritic cells (Fig. 6H). IL1- and VEGF mRNA 
levels were lower when chroidal extracts are depleted of CD11b
+
F4/80
+
 macrophages, confirming 
that macrophages are a significant source of IL1- and VEGF in the model (Fig 6 I and J 
respectively). While sDLL4 had little effect on CD11b
+
F4/80
+
 LY6B.2
low
  resident macrophages, 
IL1- and VEGF mRNA expression increased in the pooled CD11b+F4/80+ LY6B.2high 
inflammatory macrophages in the sDLL4 injected group (Fig. 6 K and L respectively). 
Immunohistochemistry of VEGF (green) and the macrophage marker F4/80 (red) of PBS (Fig. 6M) 
and sDLL4/28-525 (Fig. 6IN) injected eyes at 4d reveals F4/80 positive macrophages in both groups 
(arrows). However, in sDLL4/28-525-injected eyes macrophages positive for VEGF (double 
labelling yellow, white arrows) were more numereous.  
sDLL4 inhibits endothelial cell proliferation in CNV in vivo  
Dll4 heterozygosity or DLL4 inhibition using specific antibodies dramatically increases the number 
of tip cells and the density of the vascular plexus in retinal angiogenesis [20] [14] [12]. First, we 
screened Collagen IV stained choroidal flatmounts at different time points after laser-injury for the 
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presence of tip-cells, which could be detected at d3. To evaluate if sDLL4/28-525 changes the 
number of tip cells in CNV we counted the number of tip cells in Collagen IV stained choroidal flat 
mounts of PBS (Fig. 7A) and sDLL4/28-525 (Fig. 7B) treated mice 3 days after laser-injury. 
sDLL4/28-525 had no effect on tip-cell formation, as tip cell counts in both groups were similar 
(Fig. 7C). To study if sDLL4/28-525 changes the proliferation rate of endothelial cells in CNV in 
vivo, PBS treated (Fig. 7D and F) and sDLL4/28-525 treated (Fig. 7E and G) mice were injected 
with the artificial nucleotide EdU at day 3 and choroidal flatmounts were prepared at 24h later and 
double labeled for EdU (red) and Collagen IV (green) to allow quantification of proliferating 
endothelial cells between 3 and 4 days. Quantification of Collagen IV EdU double-positive cells 
were significantly decreased in sDLL4/28-525 injected animals (Fig. 7H). 
Discussion 
DLL4 induced Notch signaling inhibits angiogenesis in a variety of models [9, 13, 43]. Pathological 
neovascularization, such as choroidal neovascularization (CNV), occur in the presence of Notch 
expressing macrophages in an inflammatory setting. The influence of DLL4 signaling on 
macrophages with regard to angiogenesis and its overall effect in inflammatory neovascularization is 
not well understood. We here analyzed the potential influence of DLL4 signaling in choroidal 
neovascularization a model of “wet” AMD using Dll4+/- animals and local administration of soluble 
DLL4 (Ser28-Pro525, a part of the extracellular domain of DLL4 with a 10 His tag) and the -
secretase inhibitor DAPT. We identified macrophages and endothelial cells as the main Notch1 and 
Notch 4 expressing cells in CNV. Soluble DLL4 (sDLL4/28-525) activated Notch pathway in vitro, 
as it induces the expression of specific Notch target genes in macrophages and ECs. Similarly, 
sDLL4/28-525 developed agonistic properties in vivo, as it inhibited the exacerbated CNV of Dll4
+/-
 
CD1 mice and CNV in C57/Bl6 wild type mice, which was abrogated with Notch signaling inhibitor 
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DAPT. Reduced neovascularization in C57/Bl6 mice occurred albeit increased VEGF release by 
macrophages in vitro and in vivo. More generally, DLL4 signaling in activated macrophages leads to 
an accentuation of their angiogenic potential, demonstrated by increased vascular sprouting in aortic 
rings exposed to supernatants from sDLL4/28-525 incubated activated macrophages as compared to 
supernatants from activated macrophages in the absence of sDLL4/28-525. Thus sDLL4/28-525-
induced inhibition of CNV might be attributed to a direct effect on endothelial cell proliferation that 
we demonstrate in vitro and in vivo. 
DLL4 exerts its effect mainly via Notch 1 and Notch 4 [10, 16], while its affinity to Notch 3 is low 
[17]. To test the expression pattern of Notch 1 and Notch 4 in an inflammatory neovascularization 
we studied laser-induced CNV in mice eyes. In laser-induced CNV Notch 1 and Notch 4 expression 
was identified in macrophages, identified by CD68, but also in activated vascular endothelium, 
identified by CD31 positivity, in the vicinity of the laser burn (Fig. 1). We also confirmed the 
previously described expression of Notch 1 [28] [29] [30] but also Notch 4 on macrophages by flow 
cytometry on CD11b, F4/80 expressing thioglycollate elicited peritoneal macrophages (Fig.2). Our 
results show that macrophages and activated endothelial cells are potentially DLL4 sensitive in 
inflammatory neovascularization such as CNV. 
Soluble Notch ligands can act as agonists [5-7, 44] or antagonists [8] [9]. It has been postulated that 
Notch ligand extracellular domains have to be immobilized to activate Notch [4]. A soluble 
extracellular construct of DLL4 (amino acid residues 1-486 with a C-terminal His tag) has been 
shown to inhibit Notch signaling, evaluated by Notch target gene expression HES1 and HEY1 in 
vitro [17]. To influence Notch signaling we purchased the commercially available mouse soluble 
DLL4, composed of Ser28 - Pro525 with a C-terminal 10-His tag. Surprisingly, the mouse 
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sDLL4/28-525 induced the Notch target gene HES1 the -secretase dependently in macrophages 
similarly to surface-fixed sDLL4/28-525 and it led to the cleavage of the Notch4 intracellular 
domain in macrophages (Fig. 2). In HUVECs sDLL4/28-525 induced Notch target genes HES1 and 
HEY1 in a the -secretase dependent fashion, but less potently compared to macrophages and might 
only partially activate the Notch pathway (Fig. 3). Nevertheless, it inhibited ECs proliferation in 
vitro (Fig. 2, Fig. 3 and Fig.6) as previously shown for DLL4 dependent Notch activation [20]. 
Moreover, it inhibited the exacerbated CNV of Dll4
+/- 
CD1 mice and diminished CNV in C57BL6 
mice in a Notch dependent fashion, as DAPT reversed its effect (Fig. 5). Taken together our data 
shows that the mouse sDLL4 Ser28 - Pro525 activates Notch signaling in vitro and in vivo which is 
somewhat in contradiction with previous reports of a slightly longer human construct [17] and casts 
doubt on the paradigm that the Notch ligand extracellular domains have to be immobilized to 
activate Notch [4]. Similarly, amino acids 188-204 of the Notch ligand Jagged1 activates Notch in 
vitro and in vivo without immobilization [6, 7] suggesting that other factors determine the biological 
activity of Notch ligands. DLL4 and Notch signaling have been shown to down regulate VEGF 
receptor (VEGFR) expression on stalk cells [12-14] and inhibit angiogenesis in vitro and in vivo [7, 
9, 12-15, 17-22]. We here show that sDLL4/28-525 inhibited vascular sprouting significantly in the 
aortic ring assay (Fig. 4), which confirms that the murine sDLL4/28-525 activates the Notch 
pathway in vitro, as aortic rings prepared from Dll4
+/-
 mice develop significantly more vascular 
sprouts [12]. These findings underline the necessity to evaluate Notch activity of the different 
constructs and in different biological settings individually. 
In neovascularization observed in ischemia, tumor growth and inflammatory conditions, infiltrating 
cells from the myeloid lineage (macrophages / microglia cells) are key players [23-25]. Notch 
pathway activation on bone marrow derived macrophages affects their cytokine expression profile 
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[30, 31]. Although macrophages secrete a variety of pro- and anti-angiogenic mediators and no 
single factor determines their overall effect on neovascularization, we here show that sDLL4/28-525 
induces VEGF, IL1-, IL-6 and TNF- in macrophages (Fig. 2), but also pro-inflammatory factors 
such as CCL2 and IL-12 (data not shown). To test the effect of macrophage Notch activation on 
their overall angiogenic potential, we grew aortic rings in culture medium from sDLL4/28-525 or 
control stimulated macrophages. Our data shows, that sDLL4/28-525 leads to a significant shift 
towards increased angiogenicity in macrophages (Fig. 4). This shift was Notch pathway dependent, 
as it was preventable when macrophages were co-incubated with the -secretase inhibitor DAPT. 
More specifically the pro-angiogenic effect of conditioned medium from sDLL4/28-525 stimulated 
activated macrophages depended on VEGF and IL1-, as their inhibition reversed the proangiogenic 
effect of the conditioned macrophage medium. 
  
To evaluate how DLL4 influences CNV in vivo, we compared CNV elicited by a cryo-injury in 
Dll4
+/+
 CD1 and Dll4
+/-
 CD1 mice. We show that Dll4
+/-
 mice develop significantly more CNV than 
Dll4
+/+
 control mice. sDLL4/28-525 injections, on the other hand, inhibited the exacerbated CNV 
Dll4
+/-
 mice, suggesting that sDLL4/28-525 also acts as a DLL4 agonist in vivo (Fig. 5). Similarly, 
sDLL4/28-525 inhibited CNV and Notch signaling inhibitor reversed its effect in the classically used 
laser-induced CNV model of C57Bl6 mice.  
While the overall effect of DLL4 on CNV in vivo was antiangiogenic, we next evaluated its 
influence on macrophages (Fig. 5) in vivo. DLL4 inhibition has been shown to increase leucocyte 
recruitment and inhibit neovascularization in the ischemic hindlimb [9]. We show that leukocyte 
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recruitment to the laser-induced injury is independent of local DLL4 signalling, as IBA-1 positive 
macrophage/microglial cell prevalence in PBS and sDLL4/28-525 at 4d were comparable. We have 
shown that Notch activation induces VEGF, IL1-, IL-6 and TNF- in activated macrophages in 
vitro (Fig. 2) and increases the angiogenic potential in aortic rings in a VEGF / IL1- dependent 
fashion (Fig. 4). Similarly, sDLL4/28-525 injections in vivo significantly increased intraocular IL1-
, VEGF mRNA and VEGF protein concentrations at 4d, when macrophage recruitment is maximal 
[45]. Our data from rt-PCR performed on choroidal cell suspensions shows the important 
contribution of CD11b
+
F4/80
+
 macrophages in IL1- and VEGF mRNA production and a 
sDLL4/28-525 dependent induction in CD11b
+
LY6B.2
high
 inflammatory macrophages in vivo. 
VEGF immunohistochemistry at 4d after laser injury confirms F4/80 positive activated macrophages 
as a major source of VEGF in sDLL4/28-525 injected eyes (Fig. 6). In view of Notch activating 
agent as therapeutics of inflammatory neovascularization, our results suggest that DLL4 signaling in 
activated macrophages in CNV in vivo can induce VEGF and possibly an angiogenic macrophage 
phenotype similar to that observed in vitro (Fig. 2 and 4).  
Albeit the possibly proangiogenic effect of sDLL4/28-525 injections on macrophages, DLL4 
signaling significantly inhibits CNV (Fig. 4). This effect is possibly mediated by a direct effect on 
endothelial cells. DLL4 inhibition, by genetic or pharmacological means, prevents the differentiation 
of stalk cells into tip cells and their proliferation [12-14]. Our data shows, that Notch stimulation by 
sDLL4/28-525 injections did not increase the tip cell count, making this mechanism unlikely in our 
experimental setting. To evaluate the endothelial cell proliferation rate in CNV we systemically 
administered EdU in laser-injured mice at d3 and evaluated EdU
+
CollagenIV
+
cells at d4 (Fig.7). 
EdU
+
CollagenIV
+
cells were significantly less numereous in sDLL4/28-525 eyes demonstrating a 
significant inhibition of endothelial cell proliferation over the relatively short time span of 24 hours. 
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DLL4 has been shown to inhibit EC proliferation in vitro and in vivo [20] [12]. The suggestion that 
DLL4 regulates EC proliferation by VEGFR2 downregulation has recently been challenged [46]. In 
our hands the observed sDLL4/28-525 induced inhibition of VEGF induced HUVEC proliferation 
was not accompagnied by an alteration of VEGFR2 mRNA (data not shown) suggesting an 
alternative pathway. 
Taken together, we show that the soluble protein composed of the extracellular domain Ser28-
Pro525 of murine DLL4 activates Notch as it induces Notch target genes, and it has the opposite 
effect of Dll4 heterozygosity in vitro and in vivo (vascular sprouting in aortic rings, and CNV). Our 
data shows that DLL4 signaling, although it accentuates the angiogenic potential of macrophages, 
inhibits neovascularization in an inflammatory setting possibly by a direct effect on endothelial cell 
proliferation. 
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 Figure legends 
Figure 1: Notch1 and 4 expressions in mice during laser induced CNV. Confocal microscopy 3 
days post laser induced CNV in mice: expression of Notch1 (green, A, C, G and I), endothelial cell 
marker CD31 (red, B, C, E and F), Notch 4 (green, G, I, J and L),macrophage marker CD68 (red H, 
I, K and L).. Colocalization appears in yellow. Confocal microscopy optical section is 1.5m; scale 
bars represent 20m in A to F and 100m in G to L. All staining were performed 3 times with 
similar results. ONL: outer nuclear layer; CHO: choroid. 
Figure 2: sDLL4 activates Notch signaling and induces proangiogenic mediators in 
macrophages in vitro: Flow cytometry of F4/80
+
 CD11b
+
 macrophages (A), Notch1 (B) Notch4 (C) 
and DLL4 (D). HES-1 mRNA expression by PECs cultivated on sDLL4 coated plates (DLL4an = 
DLL4anchored) (E, PBS, white, n=3, DLL4an, black, n=3). HES-1 mRNA expression of soluble (s) 
DLL4 stimulated macrophages (F, PBS, white, n=6 and sDLL4, black, n=4). Western blotting of 
Notch-4 intracellular domain (N4-ICD) in macrophages stimulated with PBS or sDLL4 (G). mRNA 
expression in sDLL4 and sDLL4 and DAPT treated C57BL/6j activated macrophages of HES-1 (H), 
VEGF (I), IL-1 (J), IL-6 (K) and TNF- (L). (LPS n= 4 white, LPS + sDLL4 n=4 black, LPS + 
sDLL4 +DAPT n=4 grey) * = p < 0.05, ** = p < 0.01. 
Figure 3: sDLL4 activates Notch in HUVECs and inhibits their proliferation: HES-1 (A, 
Control (CTL), white n=12; sDLL4, black, n=12, sDLL4+DAPT, grey, n=6) and HEY-1 (B, CTL, 
white, n=12; sDLL4, black, n=12, sDLL4+DAPT, grey, n=6) mRNA expression by HUVEC 
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stimulated with sDLL4 in vitro. Effect of sDLL4 on VEGF-induced HUVEC proliferation (C, CTL, 
white,  n=3, VEGF, grey n=3, VEGF + sDLL4, black, n=2) performed in triplicates. Percentage of 
TUNEL
+
 cells following starvation (D, CTL, white, n=3, VEGF, grey, n=3, VEGF + sDLL4, black, 
n=2). Percent of apoptotic, or necrotic (E) HUVEC stimulated with VEGF (grey) or VEGF+sDLL4 
(black) in minimum medium detected by annexinV – Propidium iodide staining by flow cytometry 
(n=5). * = p < 0.05 
Figure 4: sDLL4 directly inhibits vascular sprouting but accentuates the angiogenic phenotype 
of activated macrophages in vitro. Photographs of aortic rings at day 5, incubated with PBS (A), or 
sDLL4 (B). (C) Areas of vascular sprouting in the presence of PBS (white, n=16) or sDLL4 (black, 
n=15) between day 3 and 6 and expressed as percentage of the aortic ring area at day 3, * = p < 0.01. 
Photographs of aortic rings at day 5, incubated with conditioned medium of macrophages stimulated 
4 hours with LPS (D), or LPS + sDLL4 (E). F and G) Quantification of areas of vascular sprouting 
between day 3 and 5 and expressed as percentage of the aortic ring area at day 3. F) effect of sDLL4 
conditionned macrophage medium : supernatant of activated macrophages (white, n=8); supernatant 
of sDLL4 stimulated activated macrophages (black, n=8); supernatant  of sDLL4 +DAPT stimulated 
activated macrophages (grey, n=8)). G) effect of VEGF/ Il-1inhibition on sDLL4 conditionned 
macrophage medium: supernatant of activated macrophages (white, n=8), supernatant of sDLL4 
stimulated activated macrophages (black, n=8); supernatant of sDLL4 stimulated activated 
macrophages supplemented with  sVEGFR1 and IL1Ra (grey, n=8). Sn=supernatant; * = p < 0.001.  
Scale bar: 50m  
Figure 5: sDLL4 activates the Notch pathway in vivo and significantly inhibits choroidal 
neovascularization (CNV). Representative CD102- stained choroidal flatmount 14 days after cryo-
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injury induced CNV in Dll4
+/+
 (A), Dll4
+/-
 mice (B) and a Dll4
+/-
 mice injected with sDLL4 (C). D) 
Quantification of surface covered by CNV in Dll4
+/+
 (white, n=18 lesions), Dll4
+/-
 (black, n=19 
lesions) and sDLL4 injected Dll4
+/-
 mice (grey, n=7 lesions) * = p < 0.05. Representative Collagen 
IV (Col IV) -stained choroidal flatmount 7 days after laser-induced CNV in C57BL/6 mice treated 
with PBS (E), sDLL4 (F) or sDLL4 and DAPT (G). H) Quantification of surface covered by CNV in 
PBS treated mice (white, n=35 impacts), sDLL4 treated mice (black, n=30 impacts) and sDLL4 and 
DAPT treated mice (grey, n=14 impacts) * = p < 0.01. Scale bar: 100m. 
Figure 6: Influence of sDLL4 on and macrophages in CNV in vivo. Representative image of an 
IBA1-stained choroidal flatmount 4 days after laser-injury of PBS treated mice (A) or sDLL4 treated 
mice (B). Quantification of IBA1 positive cells per impact in PBS, (white, n=25 impacts) and 
sDLL4 (black, n=25 impacts) treated mice (C).  Il-1 (D) and Vegf (E) mRNA levels and VEGF 
protein concentrations (F) in choroid 4 days following CNV and 24h after PBS or sDLL4 injections 
(PBS, white, n=6 choroid, sDLL4 black, n=6 choroid). * = p < 0.001. Fluorescent activated cell 
sorting (FACS) for CD11b
 
and F4/80 (G) and LY6B.2
 
(H) on choroidal cell suspensions 4 days after 
laser-injury and 24h after PBS (white collums I-L) or sDLL4 (black columns I-L) treatment. VEGF 
(I) and Il-1 (J) rt-PCR on sorted CD11b+F4/80+LY6B.2low resident macrophages and 
CD11b
+
F4/80
+
 LY6B.2
high
 inflammatory macrophages. VEGF (K) and Il-1 (L) rt-PCR on whole 
choroidal cell suspension and CD11b
+
F4/80
+
depleted cell suspension. Choroidal cell suspensions 
were prepared from 8 choroids per group. The results are representatif of two independent 
experiments. Double labeling of VEGF (green) and F4/80 (red) on choroidal flatmounts of PBS (M) 
and sDLL4 (N) treated CNV 4d after laser-impact. Double labeling was performed on n=3 eyes / 
group. Arrows indicate F4/80 positive cells. Scale bar: 50m 
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Figure 7:  sDLL4 has no effect on Tip cells formation but inhibits endothelial cell proliferation 
in vivo. Representative image of tip cells (arrows) in a Collagen IV-stained choroidal flatmount 3 
days after laser-injury in PBS (A) and sDLL4 (B) treated mice. Number of tip cells per impact (C, 
PBS, white, n=22 impacts; sDLL4, black n=23 impacts). Double labelling of EdU (D to G, red) and 
Collagen IV (E and G green) on choroidal flatmounts of PBS (D and E) and sDLL4 (F and G) 
treated CNV 4d after laser-impact. Quantification of EdU
+
Collagen IV
+
 endothelial cells (H, PBS, 
white,  n=14 impacts; DLL4, black, n=18 impacts). * = p < 0.05, Col IV = Collagen IV. Scale bar in 
A to G: 50m  
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Supplementary data: 
Supplementary figure 1: Cryo-injury induced choroidal neovascularization:  
Choroidal flatmounts of C57BL/6j (A) and CD1 (B) in CD102 stained choroidal flatmounts 14d 
after liquid nitrogen cooled 30gauge syringe induced cryo injury. 
 
 
